A federal judge issued a preliminary injunction against a new government pilot set to significantly shift how certain ...
On May 28, representatives from three states introduced a federal bill to amend the 340B program by recognizing contract pharmacies, restricting pharmacy benefit managers and tightening eligibility ...
“340B is a valuable program, but it doesn't always work the way Congress intended,” said Stephanie Silverman, an AIR 340B spokesperson. Overly-broad eligibility criteria for hospitals have led to an ...
The AHA and several safety-net providers argue that an upcoming mandatory rebate pilot violates administrative law, imposes millions in costs, and threatens patient care in vulnerable communities.
Healthcare policy changes may increase uncompensated care, stressing hospitals and the 340B program, crucial for subsidizing low-income patient care. The 340B rebate model, starting in 2026, could ...
As we look ahead to 2026, the operational demands on 340B programs are increasing across every dimension. Between the implementation of the 340B ...
Michigan hospitals are systematically exploiting a program for low-income patients, according to a new report.
The 340B Drug Pricing Program continues to provide critical support for covered entities, although the program is subject to ongoing scrutiny and congressional, judicial, and industry pressures.
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.
The 340B Drug Pricing Program (“340B Program”) space continues to be a hive of activity. While 340B stakeholders continue to litigate ongoing manufacturer contract pharmacy restrictions, states ...
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback